Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Share-Based Payment Transactions (Tables)

v3.8.0.1
Share-Based Payment Transactions (Tables)
 12 Months Ended
Dec. 31, 2017
Share-based Payment Transactions  
Schedule of Expenses
      Year ended December 31,  
      2017     2016     2015  
      NIS in thousand  
                     
  Research and development expenses     502       495       207  
  General and administrative expenses     176       676       235  
                           
        678       1,171       442  
Summary of weighted average exercise prices and modification in option plans of employees, directors and consultants
      Shares subject to options outstanding  
      2017     2016     2015  
      Number     Weighted
average
exercise
price		     Number     Weighted
average
exercise
price		     Number     Weighted
average
exercise
price		  
            NIS           NIS           NIS  
  Outstanding at beginning of year     737,028       10.12       798,579       12.21       592,707       15.33  
  Grants     970,000       2.71       180,000       4.43       240,000       4.33  
  Forfeited/expired     (216,605 )     15.34       (241,551 )     12.79       (34,128 )     10.96  
                                                   
  Outstanding at end of year     1,490,423       4.68       737,028       10.12       798,579       12.21  
                                                   
  Exercisable at end of year     451,266       8.39       402,500       14.90       557,749       15.56  
Summary of estimated using the binomial option pricing model
      December 31,
  Description   2017   2016
           
  Risk-free interest rate   1.89%-2.31%   2.01%-2.02%
  Expected volatility   74.4%-77.64%   77.84%-78.22%
  Dividend yield   0   0
  Contractual life   10   10
  Early Exercise Multiple (Suboptimal Factor)   2.5   2.5
  Exercise price   2.513-3.393   4.317-5.376